Establishment of a [18F]-FDG-PET/MRI Imaging Protocol for Gastric Cancer PDX as a Preclinical Research Tool

scientific article published on 21 February 2020

Establishment of a [18F]-FDG-PET/MRI Imaging Protocol for Gastric Cancer PDX as a Preclinical Research Tool is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.5230/JGC.2020.20.E7
P932PMC publication ID7105419
P698PubMed publication ID32269845

P50authorFelix BerlthQ61161489
June-Key ChungQ85504034
Seong-Ho KongQ88391528
Han-Kwang YangQ89127617
Yun-Suhk SuhQ89340459
Hyuk Joon LeeQ89340462
Woo Ho KimQ89795553
Seong-Woo BaeQ91743843
Kyoung-Yun JeongQ91743847
P2860cites work18F-FDG PET/CT for Very Early Response Evaluation Predicts CT Response in Erlotinib-Treated Non-Small Cell Lung Cancer Patients: A Comparison of Assessment MethodsQ50657799
Simultaneous Multiparametric PET/MRI with Silicon Photomultiplier PET and Ultra-High-Field MRI for Small-Animal Imaging.Q51370519
Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study).Q54986076
A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samplesQ64019066
Routinely staging gastric cancer with F-FDG PET-CT detects additional metastases and predicts early recurrence and death after surgeryQ64289746
A correlation study between maximum standardized uptake values and pathology and clinical staging in nonsmall cell lung cancerQ84398281
The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancerQ89285151
Imaging strategies in the management of gastric cancer: current role and future potential of MRIQ91793873
Monitoring the Growth of an Orthotopic Tumour Xenograft Model: Multi-Modal Imaging Assessment with Benchtop MRI (1T), High-Field MRI (9.4T), Ultrasound and Bioluminescence.Q27344437
Current status and perspectives of patient-derived xenograft models in cancer researchQ33667686
Development of orthotopic pancreatic tumor mouse modelsQ33726528
In vivo imaging of pancreatic tumours and liver metastases using 7 Tesla MRI in a murine orthotopic pancreatic cancer model and a liver metastases modelQ33806343
Correlation of Primary Tumor FDG Uptake with Histopathologic Features of Advanced Gastric CancerQ35724980
Multimodal Imaging of Orthotopic Mouse Model of Endometrial CarcinomaQ35740059
Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer.Q36633405
PET designated flouride-18 production and chemistryQ36742964
Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodulesQ36926680
(18)F-FDG PET/CT for Monitoring the Response of Breast Cancer to miR-143-Based Therapeutics by Targeting Tumor GlycolysisQ37256225
Correlation of Positron Emission Tomography/Computed Tomography Scan with Smoking, Tumor Size, Stage and Differentiation in Head and Neck Cancer PatientsQ37649216
Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular ClassificationsQ38723978
Metabolic Evaluation of Non-Small Cell Lung Cancer Patient-Derived Xenograft Models Using 18F-FDG PET: A Potential Tool for Early Therapy Response.Q38739226
Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma.Q38983876
Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival.Q41068710
Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expressionQ43134569
The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignanciesQ44987679
Impact of animal handling on the results of 18F-FDG PET studies in mice.Q46109682
Validation of 2-mm tissue microarray technology in gastric cancer. Agreement of 2-mm TMAs and full sections for Glut-1 and Hif-1 alphaQ46219662
Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancerQ46755986
Bridging the divide: preclinical research discrepancies between triple-negative breast cancer cell lines and patient tumorsQ49619782
P275copyright licenseCreative Commons Attribution-NonCommercial 4.0 InternationalQ34179348
P6216copyright statuscopyrightedQ50423863
P433issue1
P921main subjectFluorodeoxyglucose Positron Emission TomographyQ130273243
P304page(s)60-71
P577publication date2020-02-21
P1433published inJournal of gastric cancerQ26853794
P1476titleEstablishment of a [18F]-FDG-PET/MRI Imaging Protocol for Gastric Cancer PDX as a Preclinical Research Tool
P478volume20

Search more.